{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:57:51Z","timestamp":1790740671234,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s13555-021-00544-6","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T06:03:28Z","timestamp":1622181808000},"page":"1249-1263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Psoriasis Severity Assessment Combining Physician and Patient Reported Outcomes: The Optimal Psoriasis Assessment Tool"],"prefix":"10.1007","volume":"11","author":[{"given":"Craig","family":"Leonardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoungah","family":"See","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Missy","family":"McKean-Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orin","family":"Goldblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotus","family":"Mallbris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russel","family":"Burge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"key":"544_CR1","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","volume":"2","author":"JE Greb","year":"2016","unstructured":"Greb JE, Goldminz AM, Elder JT, et al. Psoriasis. Nat Rev Dis Primers. 2016;2:16082.","journal-title":"Nat Rev Dis Primers"},{"issue":"21 Suppl","key":"544_CR2","first-page":"S403","volume":"23","author":"JJ Wu","year":"2017","unstructured":"Wu JJ. Contemporary management of moderate to severe plaque psoriasis. Am J Manag Care. 2017;23(21 Suppl):S403\u201316.","journal-title":"Am J Manag Care"},{"issue":"5","key":"544_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/09546634.2017.1395800","volume":"29","author":"JJ Wu","year":"2018","unstructured":"Wu JJ, Feldman SR, Koo J, Marangell LB. Epidemiology of mental health comorbidity in psoriasis. J Dermatol Treat. 2018;29(5):487\u201395.","journal-title":"J Dermatol Treat"},{"issue":"2","key":"544_CR4","first-page":"147","volume":"16","author":"KC Duffin","year":"2017","unstructured":"Duffin KC, Papp KA, Bagel J, Levi E, Chen R, Gottlieb AB. Evaluation of the physician global assessment and body surface area composite tool for assessing psoriasis response to apremilast therapy: results from ESTEEM 1 and ESTEEM 2. J Drugs Dermatol. 2017;16(2):147\u201353.","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"544_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000250839","volume":"157","author":"T Fredriksson","year":"1978","unstructured":"Fredriksson T, Pettersson U. Severe psoriasis\u2014oral therapy with a new retinoid. Dermatologica. 1978;157(4):238\u201344.","journal-title":"Dermatologica"},{"key":"544_CR6","volume-title":"National Institute for Health and Clinical Excellence: guidance. Psoriasis: assessment and management of psoriasis","author":"National Clinical Guideline Centre","year":"2012","unstructured":"National Clinical Guideline Centre. National Institute for Health and Clinical Excellence: guidance. Psoriasis: assessment and management of psoriasis. London: Royal College of Physicians; 2012."},{"issue":"8","key":"544_CR7","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/jdv.14960","volume":"32","author":"C Fink","year":"2018","unstructured":"Fink C, Alt C, Uhlmann L, Klose C, Enk A, Haenssle HA. Intra- and interobserver variability of image-based PASI assessments in 120 patients suffering from plaque-type psoriasis. J Eur Acad Dermatol Venereol. 2018;32(8):1314\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"544_CR8","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1111\/jdv.13089","volume":"29","author":"IF Manalo","year":"2015","unstructured":"Manalo IF, Gilbert KE, Wu JJ. An updated survey for the 2007\u20132013 period of randomized controlled trials for psoriasis: treatment modalities, study designs, comparators, outcome measures and sponsorship. J Eur Acad Dermatol Venereol. 2015;29(10):1945\u201350.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"544_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.17219\/acem\/69804","volume":"26","author":"A Bozek","year":"2017","unstructured":"Bozek A, Reich A. The reliability of three psoriasis assessment tools: psoriasis area and severity index, body surface area and physician global assessment. Adv Clin Exp Med. 2017;26(5):851\u20136.","journal-title":"Adv Clin Exp Med"},{"issue":"2","key":"544_CR10","first-page":"70","volume":"25","author":"N Mahendraratnam","year":"2019","unstructured":"Mahendraratnam N, Sorenson C, Richardson E, et al. Value-based arrangements may be more prevalent than assumed. Am J Manag Care. 2019;25(2):70\u20136.","journal-title":"Am J Manag Care"},{"issue":"3","key":"544_CR11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/bjd.16050","volume":"178","author":"KA Papp","year":"2018","unstructured":"Papp KA, Leonardi CL, Blauvelt A, et al. Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double-blinded, controlled studies (UNCOVER-1, UNCOVER-2, UNCOVER-3). Br J Dermatol. 2018;178(3):674\u201381.","journal-title":"Br J Dermatol"},{"issue":"4","key":"544_CR12","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/bjd.15666","volume":"177","author":"K Reich","year":"2017","unstructured":"Reich K, Pinter A, Lacour JP, et al. Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study. Br J Dermatol. 2017;177(4):1014\u201323.","journal-title":"Br J Dermatol"},{"issue":"5","key":"544_CR13","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s13555-020-00435-2","volume":"10","author":"AG Wu","year":"2020","unstructured":"Wu AG, Conway J, Barazani L, Roy B, Cline A, Pereira F. Is clear always clear? Comparison of Psoriasis Area and Severity Index (PASI) and the Physician\u2019s Global Assessment (PGA) in psoriasis clearance. Dermatol Ther (Heidelb). 2020;10(5):1155\u201363.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"544_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jaad.2016.10.017","volume":"76","author":"AW Armstrong","year":"2017","unstructured":"Armstrong AW, Siegel MP, Bagel J, et al. From the Medical Board of the National Psoriasis Foundation: treatment targets for plaque psoriasis. J Am Acad Dermatol. 2017;76(2):290\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"544_CR15","first-page":"418","volume":"99","author":"JJ Wu","year":"2017","unstructured":"Wu JJ, No DJ, Amin M. BSA75, BSA90, and BSA100: new clinical tools for measuring improvement in psoriasis. Cutis. 2017;99(6):418.","journal-title":"Cutis"},{"issue":"8","key":"544_CR16","first-page":"770","volume":"16","author":"LM Perez-Chada","year":"2017","unstructured":"Perez-Chada LM, Singh S, Callis-Duffin K, et al. International Dermatology Outcome Measures (IDEOM) group 2016 new york meeting: meeting summary and data from the psoriasis working group. J Drugs Dermatol. 2017;16(8):770\u20137.","journal-title":"J Drugs Dermatol"},{"issue":"9","key":"544_CR17","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.jid.2018.01.041","volume":"138","author":"JF Merola","year":"2018","unstructured":"Merola JF, Amato DA, See K, et al. Evaluation of sPGA \u00d7 BSA as an outcome measure and treatment target for clinical practice. J Invest Dermatol. 2018;138(9):1955\u201361.","journal-title":"J Invest Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00544-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-021-00544-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00544-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T04:05:58Z","timestamp":1627617958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-021-00544-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["544"],"URL":"https:\/\/doi.org\/10.1007\/s13555-021-00544-6","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,28]]},"assertion":[{"value":"10 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}